project id: TCGA-LUAD; case submitter id: TCGA-05-4384; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 66; days to birth: -24411; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1943; age at diagnosis: 24411; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 426.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: Not Reported; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; years smoked: 24.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 0.8; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-05-4384-01A-01; percent necrosis: 0.0; percent stromal cells: 10.0; percent tumor nuclei: 70.0;